14 completed, 1 unknown. 15 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 14, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Indinavir: new trials by email Literature Review of Indinavir trials Research Report on Indinavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy triple therapy, dual therapy - HIV | Phase 3 | Completed | University Hospital, Tours | 224 | 2014-12-01 | 2025-12-26 |
| Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN) Structured Treatment Interruption, Zidovudine (ZDV), Lamivudine (3TC) - HIV Infections | Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 840 | 2002-12-01 | 2008-12-30 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) - HIV Infections | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 266 | 2002-08-01 | 2021-11-05 |
| Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs Indinavir sulfate, Ritonavir, Stavudine - HIV Infections | Phase 3 | Unknown | PPD Development, LP | 200 | 2000-08-01 | 2005-06-24 |
| The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Phase 3 | Completed | Bristol-Myers Squibb | 80 | 1996-06-01 | 2011-05-04 |
| A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects. Indinavir sulfate, Lamivudine/Zidovudine, Abacavir sulfate - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 550 | 2005-06-24 | |
| Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir Indinavir sulfate, Efavirenz, Levocarnitine - HIV Infections | Phase 3 | Completed | Merck Sharp & Dohme LLC | 120 | 2005-06-24 | |
| A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1750 | 2021-11-04 | |
| A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients Indinavir sulfate, Lamivudine, Zidovudine - HIV Infections | Phase 3 | Completed | Dupont Merck | 2005-06-24 | ||
| Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen Indinavir sulfate, Lamivudine/Zidovudine, Nelfinavir mesylate - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 444 | 2012-05-21 | |
| A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection Indinavir sulfate, Ritonavir, Abacavir sulfate - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 165 | 2013-09-06 | |
| A Study of Indinavir Taken With or Without DMP 266 Indinavir sulfate, Efavirenz - HIV Infections | Phase 3 | Completed | Dupont Merck | 300 | 2005-06-24 | |
| A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Phase 3 | Completed | Merck Sharp & Dohme LLC | 400 | 2005-06-24 | |
| A Comparison of 141W94 and Indinavir in HIV-Infected Patients Indinavir sulfate, Amprenavir - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 460 | 2005-06-24 | |
| A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients Indinavir sulfate - HIV Infections | Phase 3 | Completed | Merck Sharp & Dohme LLC | 350 | 2005-06-24 |
HIV Infections (14) · Acquired Immunodeficiency Syndrome (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · Merck Sharp & Dohme LLC (3) · Dupont Merck (2) · Glaxo Wellcome (2) · Bristol-Myers Squibb (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · PPD Development, LP (1) · University Hospital, Tours (1)
United States (12) · Puerto Rico (7) · Canada (3) · Côte d’Ivoire (1) · France (1)
Ann Collier (1) · Ann J. Melvin, MD (1) · Brian Conway (1) · Christine Danel, MD (1) · Emmanuel Bissagnene, Pr (1) · Fischl MA (1) · Hammer SM (1) · Judith Feinberg (1)
PMID 12934177, PMID 14982784, PMID 15356820, PMID 15892437, PMID 16547789, PMID 16782488, PMID 18986246, PMID 20547574, PMID 21288774, PMID 24326304, PMID 31350995